Sanofi perfumes/beauty products 1995 sales "slightly up" at $774.7 mil.
This article was originally published in The Rose Sheet
SANOFI PERFUMES/BEAUTY PRODUCTS SALES "SLIGHTLY UP" AT $774.7 MIL. (FFr 3.9 bil) during 1995 on a comparable basis, Sanofi reported March 20. "Successful launches" and "efforts focused on major products" in the firm's beauty business helped offset lower sales in France in December due to public sector strikes and the "further intensification of selective distribution," Sanofi explained. Operating profit for the business grew 10% to $65.7 mil. U.S. dollar figures are based on a March 19, 1996 exchange rate of $1 = FFr 5.0345
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.